from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0653c/-

LFCtreatmentdescriptionclass of inhibitor

-0.442

Amikacinug/mL Amikacintranslation

0.452

Cap5-10ug/mL Capreomycintranslation

0.471

Rox10-50 ug/mL Roxithromycintranslation

-0.276

SM2-5 ug/mL Streptomycintranslation

3.057

Tet5-10 ug/mL Tetracyclinetranslation

-0.385

Rif0.2-5ug/mL Rifampicintranscription

-0.067

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.170

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.894

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.033

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.122

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.334

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

2.264

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.732

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.749

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.426

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.763

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.011

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.002

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.306

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

2.109

KCN5-20 ug/mL Potassium cyaniderespiration

0.417

NaN30.2-2 mM Sodium aziderespiration

-0.604

Nigericin50 uM Nigericinrespiration

-0.344

TRC10-150 ug/mL Triclosanrespiration

0.683

TRZ10-25 ug/mL Thioridazinerespiration

-0.195

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.778

menadione6-10 ug/mL Menadionerespiration

-0.256

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.200

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.221

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.930

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.145

NRP_1Non-replicating persistence stage 1dosRassociated

-0.643

Amp0.2mg/mL AmpicillincellWall

-0.252

Cephalexin20-100 ug/mL CephalexincellWall

0.182

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.384

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.533

EMB10-20 ug/mL EthambutolcellWall

0.130

Eta12-40 ug/mL EthionamidecellWall

-0.219

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.199

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.507

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.758

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.445

BZA0.12 mg/mL BenzamidearomaticAmides

-0.034

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.346

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.252

H2O24 mM hydrogen peroxideDNAdamaging

0.013

Levo10 ug/mL LevofloxacinDNAdamaging

-0.604

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.401

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.244

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.145

UVUV-irradiationDNAdamaging

2.754

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.268

Antimycin12.5-50 ug/mL Antimycin A?

-0.597

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.444

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.718

PA_2110-50 ug/mL Antitubercular compound PA-21?

2.233

PA8240.2-2 ug/mL PA-824?

1.834

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.579

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.559

Verapamil50 uM Verapamil?

-0.241

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.178

methoxatin10-20 ug/mL Methoxatin?